Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation

This study has been completed.
Information provided by (Responsible Party):
Heinrich-Heine University, Duesseldorf Identifier:
First received: November 20, 2008
Last updated: January 20, 2012
Last verified: January 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)